Afuco™ Anti-Human MMP8 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-MMP8 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies against MMP8 can be used to treat inflammation, such as but not limited to systemic inflammatory response syndrome, sepsis, LPS induced inflammation, and other inflammatory diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-512CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | MMP8 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |